Press release
Ophthalmic Drugs Market is Expanding Significantly, Globally (2017-2023) : AMR Report
The Global ophthalmic drugs market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The Retinal disorders segment accounted for 26.6% of the global ophthalmic drugs market in 2016.
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11 million people in the U.S. suffer from age-related macular degeneration (AMD), while approximately 10% of them are inflicted with wet AMD. Such trends in ophthalmic disorders across the globe contribute to the growth of the market.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/310?utm_source=opr_sank
Ophthalmic Drugs Market Key Findings:
• The liquid ophthalmic drug forms generated the highest revenue in 2016, and are anticipated to continue the same trend, registering a CAGR of 4.1% from 2017 to 2023.
• The cell therapy technologies registered significant growth rate and is expected to register a CAGR of 6.5%.
• North America dominated the market, accounting for maximum share of 36% of the total market in 2016 and is expected to witness a CAGR of 4.4%.
• The online pharmacies segment is witnessing the highest CAGR of 5.8% among the end users.
• Anti-inflammatory drugs accounted for two-sevenths share of the global ophthalmic drugs market in 2016.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma. In addition, the dynamics in the demographics across the globe contribute to the market growth. However, risk of side effects associated with ophthalmic drugs and the longer timelines required for novel ophthalmic drugs hamper this growth. Moreover, increase in investment by market players in emerging economies offers lucrative opportunities for market growth in near future.
Indication Segment Review:
The ophthalmic drugs industry is segmented based on indication into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. The retinal disorders segment is further classified into wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others. Retinal disorders indication has registered significant growth rate, registering a CAGR of 5.8% from 2017 to 2023. The dry age-related macular degeneration segment accounts for the highest share among all the retinal disorders in 2016, and is expected to continue this trend throughout the forecast period.
For More Info on Ophthalmic Drugs Market visit @ https://www.prnewswire.com/news-releases/global-ophthalmic-drugs-market-expected-to-reach-42663-million-by-2023---allied-market-research-657703433.html
Dosage Form Segment Review:
The ophthalmic drugs industry analysis is segmented based on dosage form into liquid, solid, semisolid, multicompartment drug delivery systems, and other ophthalmic drug forms. Liquid ophthalmic drug form segment accounted for the highest revenue in 2016, and is projected to maintain the trend throughout the forecast period. However, multicompartment drug delivery systems registered the highest CAGR of 8.0%. This is attributed to increase in development of novel ocular drug delivery approaches including nanoparticles, noisome, and dendrimers.
Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America dominates the global market, accounting for 36% of the total market share in 2016, and is anticipated to lead throughout the forecast period. The report provides a comprehensive analysis of the key players operating in the global market such as Santen Pharmaceutical Co., Ltd., Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.), Shire Plc, Alcon (Novartis), Genentech, Inc. Allergan, Plc, Sun Pharmaceutical Industries Limited, Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc.
The other key players in the value chain include Abbott Medical Optics, Inc., Carl-Zeiss AG, Ellex Medical Lasers Ltd., Essilor International S.A., Hoya Corporation, Insight Vision Inc., Nidek Co.Ltd, Novagali Pharma S A, Topcon Corporation, and Ziemer Ophthalmic Systems AG.
Ophthalmic Drugs Market Key Benefits:
• The study provides an in-depth analysis with the current trends and future estimations of the global ophthalmic drugs market to elucidate the imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth is provided.
• The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of key segments of the industry is provided to understand the type of ophthalmic drugs used globally.
• Key players and their strategies are analyzed to understand the competitive outlook of the market.
Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/494210?utm_source=opr_sank
*Offer Valid Till 20th April 2019
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11 million people in the U.S. suffer from age-related macular degeneration (AMD), while approximately 10% of them are inflicted with wet AMD. Such trends in ophthalmic disorders across the globe contribute to the growth of the market.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/310?utm_source=opr_sank
Ophthalmic Drugs Market Key Findings:
• The liquid ophthalmic drug forms generated the highest revenue in 2016, and are anticipated to continue the same trend, registering a CAGR of 4.1% from 2017 to 2023.
• The cell therapy technologies registered significant growth rate and is expected to register a CAGR of 6.5%.
• North America dominated the market, accounting for maximum share of 36% of the total market in 2016 and is expected to witness a CAGR of 4.4%.
• The online pharmacies segment is witnessing the highest CAGR of 5.8% among the end users.
• Anti-inflammatory drugs accounted for two-sevenths share of the global ophthalmic drugs market in 2016.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma. In addition, the dynamics in the demographics across the globe contribute to the market growth. However, risk of side effects associated with ophthalmic drugs and the longer timelines required for novel ophthalmic drugs hamper this growth. Moreover, increase in investment by market players in emerging economies offers lucrative opportunities for market growth in near future.
Indication Segment Review:
The ophthalmic drugs industry is segmented based on indication into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. The retinal disorders segment is further classified into wet age-related macular degeneration, dry age-related macular degeneration, diabetic retinopathy, and others. Retinal disorders indication has registered significant growth rate, registering a CAGR of 5.8% from 2017 to 2023. The dry age-related macular degeneration segment accounts for the highest share among all the retinal disorders in 2016, and is expected to continue this trend throughout the forecast period.
For More Info on Ophthalmic Drugs Market visit @ https://www.prnewswire.com/news-releases/global-ophthalmic-drugs-market-expected-to-reach-42663-million-by-2023---allied-market-research-657703433.html
Dosage Form Segment Review:
The ophthalmic drugs industry analysis is segmented based on dosage form into liquid, solid, semisolid, multicompartment drug delivery systems, and other ophthalmic drug forms. Liquid ophthalmic drug form segment accounted for the highest revenue in 2016, and is projected to maintain the trend throughout the forecast period. However, multicompartment drug delivery systems registered the highest CAGR of 8.0%. This is attributed to increase in development of novel ocular drug delivery approaches including nanoparticles, noisome, and dendrimers.
Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America dominates the global market, accounting for 36% of the total market share in 2016, and is anticipated to lead throughout the forecast period. The report provides a comprehensive analysis of the key players operating in the global market such as Santen Pharmaceutical Co., Ltd., Bausch & Lomb Inc. (Valeant Pharmaceuticals International, Inc.), Shire Plc, Alcon (Novartis), Genentech, Inc. Allergan, Plc, Sun Pharmaceutical Industries Limited, Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc.
The other key players in the value chain include Abbott Medical Optics, Inc., Carl-Zeiss AG, Ellex Medical Lasers Ltd., Essilor International S.A., Hoya Corporation, Insight Vision Inc., Nidek Co.Ltd, Novagali Pharma S A, Topcon Corporation, and Ziemer Ophthalmic Systems AG.
Ophthalmic Drugs Market Key Benefits:
• The study provides an in-depth analysis with the current trends and future estimations of the global ophthalmic drugs market to elucidate the imminent investment pockets.
• Comprehensive analysis of the factors that drive and restrict the market growth is provided.
• The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of key segments of the industry is provided to understand the type of ophthalmic drugs used globally.
• Key players and their strategies are analyzed to understand the competitive outlook of the market.
Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/494210?utm_source=opr_sank
*Offer Valid Till 20th April 2019
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
